-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexeo Therapeutics announces annual shareholder meeting

PUBT·04/30/2026 11:03:14
Listen to the news
Lexeo Therapeutics announces annual shareholder meeting
  • Lexeo Therapeutics scheduled 2026 annual stockholder meeting for June 25, 2026, to be held virtually.
  • Shareholders will vote on election of three Class III directors: R. Nolan Townsend, Brenda Cooperstone, Paula HJ Cholmondeley.
  • Meeting agenda includes ratification of KPMG as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-193930), on April 30, 2026, and is solely responsible for the information contained therein.